A soluble form of CD36 (sCD36) has previously been demonstrated to be present in circulation, and increased levels have been associated with abdominal fat distribution [14], insulin resistance [15], and non-alcoholic fatty liver disease (NAFLD) [16]. The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.